Optogenetic Stimulation Reduces Neuronal Nitric Oxide Synthase Expression After Stroke

Transl Stroke Res. 2021 Apr;12(2):347-356. doi: 10.1007/s12975-020-00831-y. Epub 2020 Jul 13.

Abstract

Post-stroke optogenetic stimulation has been shown to enhance neurovascular coupling and functional recovery. Neuronal nitric oxide synthase (nNOS) has been implicated as a key regulator of the neurovascular response in acute stroke; however, its role in subacute recovery remains unclear. We investigated the expression of nNOS in stroke mice undergoing optogenetic stimulation of the contralesional lateral cerebellar nucleus (cLCN). We also examined the effects of nNOS inhibition on functional recovery using a pharmacological inhibitor targeting nNOS. Optogenetically stimulated stroke mice demonstrated significant improvement on the horizontal rotating beam task at post-stroke days 10 and 14. nNOS mRNA and protein expression was significantly and selectively decreased in the contralesional primary motor cortex (cM1) of cLCN-stimulated mice. The nNOS expression in cM1 was negatively correlated with improved recovery. nNOS inhibitor (ARL 17477)-treated stroke mice exhibited a significant functional improvement in speed at post-stroke day 10, when compared to stroke mice receiving vehicle (saline) only. Our results show that optogenetic stimulation of cLCN and systemic nNOS inhibition both produce functional benefits after stroke, and suggest that nNOS may play a maladaptive role in post-stroke recovery.

Keywords: Brain stimulation; Functional recovery; Nitric oxide synthase; Optogenetics; Stroke.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Mice
  • Neurons
  • Nitric Oxide
  • Nitric Oxide Synthase Type I / genetics
  • Optogenetics*
  • Recovery of Function
  • Stroke* / therapy

Substances

  • Nitric Oxide
  • Nitric Oxide Synthase Type I
  • Nos1 protein, mouse